65 results
424B3
SLGL
Sol-Gel Technologies Ltd
20 May 24
Prospectus supplement
4:05pm
an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation for the treatment of rare hyper
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
20 May 24
Sol-Gel Reports First Quarter 2024 Financial Results and Provides
7:15am
that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation for the treatment of rare hyper-keratinization disorders.
For additional
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
1 Apr 24
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to
7:15am
that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
POS AM
SLGL
Sol-Gel Technologies Ltd
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
as a result of an investigation or proceeding filed against the office holder by an authority authorized to conduct such investigation or proceeding … , provided that such investigation or proceeding was either (i) concluded without the filing of an indictment against such office holder and without
6-K
EX-99.1
vn95bgo59x4is6si
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
6-K
EX-99.1
uq8m fj8vc1zvbh
30 Nov 23
Current report (foreign)
7:10am
424B3
3t87pm7vmze4z
9 Nov 23
Prospectus supplement
3:41pm
6-K
EX-99.1
aycix
9 Nov 23
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
424B3
mm0yr txxxqqq6
10 Aug 23
Prospectus supplement
7:20am
6-K
EX-99.1
1ekc8q fae9n
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
vtxd gu5w8j9keb5721w
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
424B3
vf4skc
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
ew7qf 9hxtqzpz2nsavo
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am
6-K
EX-99.1
adhu45w pl3tvkyv
21 Nov 22
Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:42pm